The Antiarrhythmic Medicine sales in Chile experienced consistent growth over the last years. For the past year, sales stood at 11.9 Million US Dollars in 2023.
Based on forecasted data, we observe a stable year-on-year growth rate:
- 2023 to 2024: 7.6%
- 2024 to 2025: 7.8%
- 2025 to 2026: 7.2%
- 2026 to 2027: 6.8%
- 2027 to 2028: 6.6%
The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is projected to be approximately 7.2%, indicating solid and stable growth in the antiarrhythmic medicine market.
Future trends to watch for include potential innovations in antiarrhythmic treatments, regulatory changes, and demographic shifts such as an aging population which may drive further increases in demand.
